Abstract
At least two cellular processes are required for corneal epithelium homeostasis and wound repair: cell proliferation and cell-cell adhesion. These processes are delicately balanced to ensure the maintenance of normal epithelial function. During wound healing, these processes must be reprogrammed in coordination to achieve a rapid re-epithelialization. Basonuclin (Bnc1) is a cell-type-specific transcription factor expressed mainly in the proliferative keratinocytes of stratified epithelium. This study demonstrates that basonuclin-null mutation disrupts corneal epithelium homeostasis and delays wound healing by impairing cell proliferation. In basonuclin-null cornea epithelium, RNA polymerase I (Pol I) transcription is perturbed, affecting a specific subset of ribosomal RNA genes (rDNA). Furthermore, basonuclin-null mutation perturbs RNA polymerase II (Pol II) transcripts from genes encoding chromatin structure proteins, transcription factors, and junction proteins. Our study establishes basonuclin as a critical regulator that coordinates ribosome biogenesis and protein-coding gene expression to maintain corneal health.
Introduction
The corneal epithelium serves as a vital barrier, requiring constant self-renewal to maintain its integrity. This homeostasis relies on a precise balance between cell proliferation in the basal layers and shedding at the surface. When the cornea is injured, this balance must shift rapidly toward migration and proliferation to seal the wound.
Basonuclin (Bnc1), a zinc-finger transcription factor, has long been identified in the proliferative layers of stratified epithelia, including the cornea and epidermis. While previous in vitro studies suggested Bnc1 might regulate both RNA Polymerase I (Pol I) and RNA Polymerase II (Pol II), its in vivo function remained unverified. This research by Zhang and Tseng (2007) provides the first definitive evidence of Bnc1's role in maintaining tissue homeostasis and facilitating wound repair in a living organism.
Methods and Materials
To investigate the function of Bnc1, the researchers developed a Bnc1 conditional-null mouse model using the Cre-LoxP system. By targeting Exon 4, they successfully eliminated approximately 90% of the Bnc1 protein sequence, effectively removing its functional zinc-finger domains.
The study utilized several key experimental approaches:
- Histological Analysis: H&E staining and DAPI labeling were used to quantify corneal thickness and cell density.
- Wound Healing Assays: Epithelial debridement was performed on the central cornea, and the rate of re-epithelialization was monitored via fluorescein staining.
- Molecular Profiling: The team employed RT-PCR and qPCR to measure mRNA levels. Notably, they used variant-specific RT-PCR to distinguish between seven different ribosomal DNA (v-rDNA) variants.
- Protein Verification: Immunoblotting and immunocytochemistry were conducted to correlate mRNA changes with actual protein expression levels.
Key Insights: The Coordinator of Cellular Machinery
The study reveals that Bnc1 acts as a "master coordinator" rather than a simple on/off switch. Its primary role is to synchronize two essential cellular systems:
1. Selective Ribosome Biogenesis
Bnc1 does not regulate all ribosomes equally. The researchers found that it specifically targets a subset of rDNA variants (I, II, and VI). This finding supports the "specialized ribosome" hypothesis, suggesting that cells may utilize different populations of ribosomes to translate specific sets of proteins required for specialized functions like proliferation or adhesion.
2. The E-cadherin Translational Bottleneck
One of the most striking findings was the "E-cadherin paradox." In Bnc1-null mice, the mRNA levels for E-cadherin—a critical protein for cell-cell adhesion—actually increased by 50%. However, the actual protein levels were significantly reduced. This suggests that without the specific ribosomes regulated by Bnc1, the cell cannot efficiently translate the available E-cadherin mRNA, leading to a functional deficiency despite a transcriptional surplus.
Results: Impact on Corneal Health and Repair
The loss of Bnc1 resulted in significant physiological defects:
- Structural Thinning: The corneal epithelium in null mice was 14% thinner than in wild-type controls, accompanied by a 15% reduction in total cell count.
- Proliferative Deficit: There was a 25% decrease in the number of Ki67-positive cells, indicating a fundamental failure in the basal layer's ability to divide and replenish the tissue.
- Impaired Wound Healing: While the initial migration of cells appeared normal, the later stages of wound closure were severely compromised. At 72 hours post-injury, the wound area in Bnc1-null mice remained nearly six times larger than that of the controls.
Conclusion
This study establishes Basonuclin (Bnc1) as a central regulator of corneal epithelium homeostasis. By coordinating the transcription of a subset of ribosomal RNA genes with the expression of key protein-coding genes (such as Connexin 43, Gli2, and E-cadherin), Bnc1 ensures that the "factory capacity" of the cell matches its structural and proliferative needs. These findings highlight the complexity of epithelial maintenance and suggest that defects in such coordinating factors could underlie chronic corneal conditions or impaired healing responses.
Future research is needed to explore the potential redundancy between Bnc1 and its relative, Bnc2, and to further elucidate the precise mechanisms by which specific rDNA variants influence the translation of key structural proteins.
Source: Zhang X, Tseng H (2007) Basonuclin-Null Mutation Impairs Homeostasis and Wound Repair in Mouse Corneal Epithelium. PLoS ONE 2(10): e1087.
Summary updated